Matthew Ocko - Net Worth and Insider Trading
Matthew Ocko Net Worth
The estimated net worth of Matthew Ocko is at least $181 Million dollars as of 2025-07-24. Matthew Ocko is the Director of Rocket Lab USA Inc and owns about 3,746,192 shares of Rocket Lab USA Inc (RKLB) stock worth over $181 Million. Details can be seen in Matthew Ocko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Ocko has not made any transactions after 2025-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Ocko
Matthew Ocko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Ocko owns 6 companies in total, including Recursion Pharmaceuticals Inc (RXRX) , Zymergen Inc (ZY) , and AbCellera Biologics Inc (ABCL) among others .
Click here to see the complete history of Matthew Ocko’s form 4 insider trades.
Insider Ownership Summary of Matthew Ocko
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2021-04-15 | 10 percent owner |
| ZY | Zymergen Inc | 2021-04-21 | director |
| ABCL | AbCellera Biologics Inc | 2020-12-11 | 10 percent owner |
 | | 2025-06-13 | director |
| | 2021-11-10 | 10 percent owner |
| | 2021-11-10 | 10 percent owner |
Matthew Ocko Latest Holdings Summary
Matthew Ocko currently owns a total of 1 stock. Matthew Ocko owns 3,746,192 shares of Rocket Lab USA Inc (RKLB) as of June 13, 2025, with a value of $181 Million.
Latest Holdings of Matthew Ocko
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RKLB | Rocket Lab USA Inc | 2025-06-13 | 3,746,192 | 48.25 | 180,753,764 |
Holding Weightings of Matthew Ocko
Matthew Ocko Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Ocko has made a total of 2 transactions in Rocket Lab USA Inc (RKLB) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Rocket Lab USA Inc is the sale of 1,020,000 shares on June 13, 2025, which brought Matthew Ocko around $27 Million.
Insider Trading History of Matthew Ocko
- 1
Matthew Ocko Trading Performance
Matthew Ocko Ownership Network
Ownership Network List of Matthew Ocko
Ownership Network Relation of Matthew Ocko
Matthew Ocko Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Matthew Ocko is the 10 percent owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Christopher Gibson , Chief Financial Officer Michael Secora , and President and COO Tina Marriott Larson .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Matthew Ocko made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 274,815 shares made by Blake Borgeson , a net sale of 1,073,165 shares made by Christopher Gibson , and a net sale of 60,000 shares made by Tina Marriott Larson .
In summary, during the past 3 months, insiders sold 0 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,736,104 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,736,104 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Matthew Ocko Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Ocko. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew Ocko's mailing address is: Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
